Investing Profile

Samuel Bjork

VCInvestor
Partner at Digitalis Ventures
Photo of Samuel Bjork, Partner at Digitalis Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
7
$300M
CompanyStageDateRound SizeTotal Raised
T-Therapeutics
Series ANov 2023$60M
$60M
Co-investors: Nihal Sinha (F-Prime Capital Partners), Robert Tansley (Cambridge Innovation Capital), Graziano Seghezzi (Soffinova Partners)
EpiBiologics
Series AJul 2023$23M
$73M
Co-investors: David Schenkein (GV (Google Ventures)), Alexandra Cantley (Polaris Partners), Alaa Halawa
Bonum Therapeutics
Series ANov 2022$93M
$93M
Co-investors: Karl Handelsman (Codon Capital), John McKearn (RiverVest), Monique Schiersing (Roche Venture Fund)
Good Therapeutics
Series BDec 2021$8M
Series AMay 2020$11M
Series AJan 2019$11M
$30M
Co-investors: Monique Schiersing (Roche Venture Fund), John McKearn (RiverVest)
MollyBox
Series BNov 2019$13M
$13M